So far in 2013, 25 biotechs have raised $1.5 billion in IPOs. Nineteen were completed in the second quarter totalling $1.2 billion. The group is up a median of 26% from their postmoney valuations, ranging from -29% to +451%. (A) Median percentage change; Source: BCIQ: BioCentury Online Intelligence

Company

Date

Raised

Post-$

6/28mcap

% chg

Prosensa B.V. (NASDAQ:RNA)

6/27/13

$78.0

$455.0

$673.8

48%